Drug Trial Radar · NCT06785012
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder
Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
105
Actual
Start
Dec 26, 2024
Primary completion
Jun 25, 2026
Study completion Aug 10, 2026
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Jan 20, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate how well JNJ-89495120 works (anti-depressant effects) and how well it is tolerated as compared to placebo on reducing the symptoms of depression in participants with major depressive disorder (MDD).
Conditions
- Depressive Disorder, Major
Interventions
JNJ-89495120Drug
JNJ-89495120 will be administered.
PlaceboDrug
Placebo will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score to Day 5Time frame: Baseline up to Day 5
Locations
44 sites in 1 country. Site status is shown where the registry gives one.
UAB Huntsville Regional Medical Campus
Huntsville, Alabama
Chandler Clinical Trials
Chandler, Arizona
IMA Clinical Research PC Phoenix
Phoenix, Arizona
Noble Clinical Research
Tucson, Arizona
University of Arizona
Tucson, Arizona
CI Trials
Bellflower, California
Wake Research PRI Encino
Encino, California
National Institute Of Clinical Research
Garden Grove, California
WR-Newport Beach
Newport Beach, California
ATP Clinical Research
Orange, California
Anderson Clinical Research
Redlands, California
Artemis Institute for Clinical Research
San Diego, California
Lumos Clinical Research Center LLC
San Jose, California
Syrentis Clinical Research
Santa Ana, California
Inland Psychiatric Medical Group Inc
Temecula, California
Sunwise Clinical Research
Walnut Creek, California
Mountain View Clinical Research
Denver, Colorado
Gulfcoast Medical Research Center
Fort Myers, Florida
The Medici Medical Research
Hollywood, Florida
Advanced Research Institute of Miami
Homestead, Florida
K2 Medical Research
Maitland, Florida
Pharmax Research Clinic Inc
Miami, Florida
Wellness Research Center
Miami, Florida
Best Choice Medical and Research Service
Pembroke Pines, Florida
Interventional Psychiatry of Tampa Bay
Tampa, Florida
Health Synergy Clinical Research
West Palm Beach, Florida
Synexus Clinical Research US Inc
Atlanta, Georgia
iResearch Atlanta LLC
Decatur, Georgia
Accelerated Clinical Research Group LLC
Snellville, Georgia
University of Chicago Medical Center
Chicago, Illinois
Indiana University IU Health
Indianapolis, Indiana
DelRicht Research
New Orleans, Louisiana
CBH Health
Gaithersburg, Maryland
University of Massachusetts Medical School
Worcester, Massachusetts
Integrative Clinical Trials LLC
Brooklyn, New York
Patient Priority Clinical Sites LLC
Cincinnati, Ohio
University of Cincinnati
Cincinnati, Ohio
OSU Department of Psychiatry and Behavioral Health
Columbus, Ohio
Paradigm Research Professionals, LLC
Oklahoma City, Oklahoma
University of Pennsylvania
Philadelphia, Pennsylvania
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.